Featured on BPI Theater

BioProcess Insider Interview: Min Park, Chief Business Officer, Aton Biotech
Sponsored Content
BioProcess Insider Interview: Min Park, Chief Business Officer, Aton BiotechBioProcess Insider Interview: Min Park, Chief Business Officer, Aton Biotech

byBPI Contributor
Aug 21, 2023
How Emerging Technology Is Improving the Cell Therapy Manufacturing Landscape
Sponsored Content
How Emerging Technology Is Improving the Cell Therapy Manufacturing LandscapeHow Emerging Technology Is Improving the Cell Therapy Manufacturing Landscape
byBPI Contributor
Aug 21, 2023
Advancing Data Driven Drug Discovery
Sponsored Content
Advancing Data Driven Drug DiscoveryAdvancing Data Driven Drug Discovery
byBPI Contributor
Aug 21, 2023
Enabling and Accelerating Innovative- and Emerging- Modalities Drug Discovery Through a Global Open Platform
Sponsored Content
Enabling and Accelerating Innovative- and Emerging- Modalities Drug Discovery Through a Global Open PlatformEnabling and Accelerating Innovative- and Emerging- Modalities Drug Discovery Through a Global Open Platform
byBPI Contributor
Aug 21, 2023
Continuous Manufacturing for Better Access: A Paradigm Shift in Biologics
Sponsored Content
Continuous Manufacturing for Better Access: A Paradigm Shift in BiologicsContinuous Manufacturing for Better Access: A Paradigm Shift in Biologics
byBPI Contributor
Aug 21, 2023
Advances in Protein A Chromatography Resins
Sponsored Content
Advances in Protein A Chromatography ResinsAdvances in Protein A Chromatography Resins
byBPI Contributor
Aug 21, 2023

More from BPI Theater

The Secrets of Ensuring a Successful Process Validation Campaign at a CDMO
Sponsored Content
The Secrets of Ensuring a Successful Process Validation Campaign at a CDMO
The Secrets of Ensuring a Successful Process Validation Campaign at a CDMO
Aug 21, 2023
byBPI Contributor
One-Stop, Integrated Viral-Vector Platform for Speed to Clinic
Sponsored Content
One-Stop, Integrated Viral-Vector Platform for Speed to Clinic
One-Stop, Integrated Viral-Vector Platform for Speed to Clinic
Aug 21, 2023
byBPI Contributor
Build it Right: A Quality Perspective on the Design and Build of a Viral Vector CDMO Manufacturing Facility
Sponsored Content
Build it Right: A Quality Perspective on the Design and Build of a Viral Vector CDMO Manufacturing Facility
Build it Right: A Quality Perspective on the Design and Build of a Viral Vector CDMO Manufacturing Facility
Aug 21, 2023
byBPI Contributor
The Next Generation of Emerging Therapies and Technologies
Sponsored Content
The Next Generation of Emerging Therapies and Technologies
The Next Generation of Emerging Therapies and Technologies
Aug 21, 2023
byBPI Contributor
How Did the Pandemic Adjust the CDMO Landscape, and How Will This Sector Change Moving Forward?
Sponsored Content
How Did the Pandemic Adjust the CDMO Landscape, and How Will This Sector Change Moving Forward?
How Did the Pandemic Adjust the CDMO Landscape, and How Will This Sector Change Moving Forward?
Aug 21, 2023
+3
byS Anne Montgomery, Rich Richieriand 3 more
Adoption of New Biopharmaceutical Technologies: Case Studies from the Front Line
Sponsored Content
Adoption of New Biopharmaceutical Technologies: Case Studies from the Front Line
Adoption of New Biopharmaceutical Technologies: Case Studies from the Front Line
Aug 21, 2023
+3
byTom Ransohoff, Aaron Larsenand 3 more
BioProcess Insider Interview: Michael Schrader, Chief Executive Officer and Cofounder, Vaxess Technologies
Sponsored Content
BioProcess Insider Interview: Michael Schrader, Chief Executive Officer and Cofounder, Vaxess Technologies
BioProcess Insider Interview: Michael Schrader, Chief Executive Officer and Cofounder, Vaxess Technologies
Aug 21, 2023
byBPI Contributor
BioProcess Insider Interview: Hayley Crowe, Senior Vice President, Purolite
Sponsored Content
BioProcess Insider Interview: Hayley Crowe, Senior Vice President, Purolite
BioProcess Insider Interview: Hayley Crowe, Senior Vice President, Purolite
Aug 21, 2023
byBPI Contributor
BioProcess Insider Interview: Andrew Mears, Chief Executive Officer, Lead Candidate
Sponsored Content
BioProcess Insider Interview: Andrew Mears, Chief Executive Officer, Lead Candidate
BioProcess Insider Interview: Andrew Mears, Chief Executive Officer, Lead Candidate
Aug 21, 2023
byBPI Contributor
BioProcess Insider Interview: Luis Berrade, Senior Director, Biologics Testing Solutions, Charles River Laboratories
Sponsored Content
BioProcess Insider Interview: Luis Berrade, Senior Director, Biologics Testing Solutions, Charles River Laboratories
BioProcess Insider Interview: Luis Berrade, Senior Director, Biologics Testing Solutions, Charles River Laboratories
Aug 21, 2023
byBPI Contributor
BioProcess Insider Interview: Darren Head, Chief Executive Officer, Bionova Scientific
Sponsored Content
BioProcess Insider Interview: Darren Head, Chief Executive Officer, Bionova Scientific
BioProcess Insider Interview: Darren Head, Chief Executive Officer, Bionova Scientific
Aug 21, 2023
byBPI Contributor
BioProcess Insider Interview: Emmanuel Ligner, Chief Executive Officer, Cytiva
Sponsored Content
BioProcess Insider Interview: Emmanuel Ligner, Chief Executive Officer, Cytiva
BioProcess Insider Interview: Emmanuel Ligner, Chief Executive Officer, Cytiva
Aug 21, 2023
byBPI Contributor
BPI Europe Interview: Gareth Jones, PhenomeX
Sponsored Content
BPI Europe Interview: Gareth Jones, PhenomeX
BPI Europe Interview: Gareth Jones, PhenomeX
Jun 21, 2023
byBPI Staff
BPI Europe Interview: Christian Witz, Sim Vantage
Sponsored Content
BPI Europe Interview: Christian Witz, Sim Vantage
BPI Europe Interview: Christian Witz, Sim Vantage
Jun 21, 2023
byBPI Staff
BPI Europe Interview: James Wilkinson, Refeyn
Sponsored Content
BPI Europe Interview: James Wilkinson, Refeyn
BPI Europe Interview: James Wilkinson, Refeyn
Jun 21, 2023
byBPI Staff
BPI Europe Interview: Ike James, PhD, Medicines Patent Pool
Sponsored Content
BPI Europe Interview: Ike James, PhD, Medicines Patent Pool
BPI Europe Interview: Ike James, PhD, Medicines Patent Pool
Jun 21, 2023
byBPI Staff
BioProcess Insider Interview: Dr. Ger Brophy, Avantor
Sponsored Content
BioProcess Insider Interview: Dr. Ger Brophy, Avantor
BioProcess Insider Interview: Dr. Ger Brophy, Avantor
Sep 1, 2022
byBPI Contributor
How Our Partnerships Move Your Life-Changing Biologics to Market: Two Case Studies
Sponsored Content
How Our Partnerships Move Your Life-Changing Biologics to Market: Two Case Studies
How Our Partnerships Move Your Life-Changing Biologics to Market: Two Case Studies
Aug 26, 2022
byBPI Staff
BioProcess Insider Interview: Tom VanCott, Catalent
Sponsored Content
BioProcess Insider Interview: Tom VanCott, Catalent
BioProcess Insider Interview: Tom VanCott, Catalent
Aug 24, 2022
byBPI Contributor
BioProcess Insider Interview: Dave Backer, Oxford Biomedica
Sponsored Content
BioProcess Insider Interview: Dave Backer, Oxford Biomedica
BioProcess Insider Interview: Dave Backer, Oxford Biomedica
Aug 24, 2022
byBPI Contributor
BioProcess Insider Interview: Greg Bleck, Catalent
Sponsored Content
BioProcess Insider Interview: Greg Bleck, Catalent
BioProcess Insider Interview: Greg Bleck, Catalent
Aug 24, 2022
byBPI Contributor
BioProcess Insider Interview: Brian Finrow, Lumen Biosciences
Sponsored Content
BioProcess Insider Interview: Brian Finrow, Lumen Biosciences
BioProcess Insider Interview: Brian Finrow, Lumen Biosciences
Aug 24, 2022
byBPI Contributor
BioProcess Insider Interview: Jon Gunther, Just-Evotec Biologics
Sponsored Content
BioProcess Insider Interview: Jon Gunther, Just-Evotec Biologics
BioProcess Insider Interview: Jon Gunther, Just-Evotec Biologics
Aug 24, 2022
byBPI Contributor
BioProcess Insider Interview: Emmanuel Ligner, Cytiva
Sponsored Content
BioProcess Insider Interview: Emmanuel Ligner, Cytiva
BioProcess Insider Interview: Emmanuel Ligner, Cytiva
Aug 24, 2022
byBPI Contributor
BioProcess Insider Interview: Claudia Melara, Gamma Biosciences
Sponsored Content
BioProcess Insider Interview: Claudia Melara, Gamma Biosciences
BioProcess Insider Interview: Claudia Melara, Gamma Biosciences
Aug 24, 2022
byBPI Contributor
BioProcess Insider Interview: James Park, Samsung Biologics
Sponsored Content
BioProcess Insider Interview: James Park, Samsung Biologics
BioProcess Insider Interview: James Park, Samsung Biologics
Aug 24, 2022
byBPI Contributor
Cell and Gene Therapy Modalities: Business and Manufacturing Strategies Influencing the Decision to Develop One Therapy Type Instead of Another
Sponsored Content
Cell and Gene Therapy Modalities: Business and Manufacturing Strategies Influencing the Decision to Develop One Therapy Type Instead of Another
Cell and Gene Therapy Modalities: Business and Manufacturing Strategies Influencing the Decision to Develop One Therapy Type Instead of Another
Aug 24, 2022
byBPI Contributor
Cell and Gene Therapy: Introducing New Technologies to Compress Timelines, Increase Capacity, and Reduce Risk
Sponsored Content
Cell and Gene Therapy: Introducing New Technologies to Compress Timelines, Increase Capacity, and Reduce Risk
Cell and Gene Therapy: Introducing New Technologies to Compress Timelines, Increase Capacity, and Reduce Risk
Aug 24, 2022
byBPI Contributor
Platform Processes Accelerating AAV Vector Production from Gene to Clinic
Sponsored Content
Platform Processes Accelerating AAV Vector Production from Gene to Clinic
Platform Processes Accelerating AAV Vector Production from Gene to Clinic
Aug 24, 2022
byBPI Contributor
Building a Comprehensive Toolbox for Oligonucleotide Drug Discovery
Sponsored Content
Building a Comprehensive Toolbox for Oligonucleotide Drug Discovery
Building a Comprehensive Toolbox for Oligonucleotide Drug Discovery
Aug 24, 2022
byBPI Contributor

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: What if Your Supply Chain for Single-Use Equipment Was Robust?
Register Now: What if Your Supply Chain for Single-Use Equipment Was Robust?
Ask the Expert webcasts
ATE Webcasts
Register Now: Introducing Super Refined™ Poloxamer 188: Optimized for Mammalian Cell Culture with Exceptional Batch-to-Batch Consistency
Register Now: Introducing Super Refined™ Poloxamer 188: Optimized for Mammalian Cell Culture with Exceptional Batch-to-Batch Consistency
Insider News
See all
Dec 2 - Dec 5, 2024
The European Cell and Gene Therapy Congress for Groundbreaking Manufacturing, Commercialisation & Analytical Strategies: World renowned leaders share the latest process development, analytical and market access strategies to improve manufacturing scalability, quality and cost to propel your CGT programmes to commercial success
Learn More

Innovative Technology

Tosoh AEX Method
Sponsored Content
Improved Safety in Ion Exchange Chromatography for Empty/Full Adeno-Associated Virus Analysis
Improved Safety in Ion Exchange Chromatography for Empty/Full Adeno-Associated Virus Analysis

Oct 14, 2024

LumaCyte LFC™
Sponsored Content
Label-Free Monitoring of T-Cell Activation Using Laser Force Cytology™
Label-Free Monitoring of T-Cell Activation Using Laser Force Cytology™

Oct 14, 2024

ValGenesis CSV to CSA
Sponsored Content
The Shift from CSV to CSA
The Shift from CSV to CSA

Oct 14, 2024